McKesson Corporation
McKesson Corporation operates four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The company distributes pharmaceutical drugs and other healthcare products. RxTS connects patients, pharmacies, and providers to deliver medication solutions. Medical-Surgical Solutions offers supply distribution and logistics services to healthcare providers. The International segment provides distribution and services to customers in Europe and Canada.
Overview
Sector
Medical Distribution
Strengths
- Shows the financial signature of a durable competitive advantage (economic moat): consistently high returns on capital, returns well above its cost of capital and an asset-light, cash-generative model.
- Return on invested capital has stayed above 15% in each of the last 7 years (latest 100.0%), a hallmark of a durable competitive advantage.
- Creates economic value: ROIC of 100.0% against a cost of capital (WACC) of 6.1%, a spread of 93.9 percentage points.
- Asset-light, cash-generative model: capital expenditure takes only 0.2% of revenue and free cash flow was positive in each of the last 7 years.
- Consistent growth: revenue has compounded at 9.7% a year over 6 years, rising every year.
- Shareholder-friendly capital allocation: the share count has shrunk by 4.1% a year over the last three years through buybacks.
Weaknesses
- Our discounted cash flow target price (745.20 USD) is 30% below the current price.
- More expensive than its own history: P/FCF 23.8x vs. a historical average of 13.1x.
Key Financial Data